15963092

Source:http://linkedlifedata.com/resource/pubmed/id/15963092

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:15963092	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:15963092	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:15963092	lifeskim:mentions	umls-concept:C0032659	lld:lifeskim
pubmed-article:15963092	lifeskim:mentions	umls-concept:C0023473	lld:lifeskim
pubmed-article:15963092	lifeskim:mentions	umls-concept:C0031327	lld:lifeskim
pubmed-article:15963092	lifeskim:mentions	umls-concept:C0939537	lld:lifeskim
pubmed-article:15963092	lifeskim:mentions	umls-concept:C1274040	lld:lifeskim
pubmed-article:15963092	lifeskim:mentions	umls-concept:C0282461	lld:lifeskim
pubmed-article:15963092	pubmed:issue	1	lld:pubmed
pubmed-article:15963092	pubmed:dateCreated	2005-6-20	lld:pubmed
pubmed-article:15963092	pubmed:abstractText	This study was designed to investigate the biochemical and physiological covariates or comedications that affect the pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia (CP CML).	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:language	eng	lld:pubmed
pubmed-article:15963092	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:15963092	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15963092	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:15963092	pubmed:month	Jul	lld:pubmed
pubmed-article:15963092	pubmed:issn	0306-5251	lld:pubmed
pubmed-article:15963092	pubmed:author	pubmed-author:BoltonA EAE	lld:pubmed
pubmed-article:15963092	pubmed:author	pubmed-author:PengBB	lld:pubmed
pubmed-article:15963092	pubmed:author	pubmed-author:CapdevilleRR	lld:pubmed
pubmed-article:15963092	pubmed:author	pubmed-author:HensleyMM	lld:pubmed
pubmed-article:15963092	pubmed:author	pubmed-author:Racine-PoonAA	lld:pubmed
pubmed-article:15963092	pubmed:author	pubmed-author:GathmannII	lld:pubmed
pubmed-article:15963092	pubmed:author	pubmed-author:SchmidliHH	lld:pubmed
pubmed-article:15963092	pubmed:author	pubmed-author:IRIS Study...	lld:pubmed
pubmed-article:15963092	pubmed:author	pubmed-author:RiviereG-JGJ	lld:pubmed
pubmed-article:15963092	pubmed:issnType	Print	lld:pubmed
pubmed-article:15963092	pubmed:volume	60	lld:pubmed
pubmed-article:15963092	pubmed:owner	NLM	lld:pubmed
pubmed-article:15963092	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:15963092	pubmed:pagination	35-44	lld:pubmed
pubmed-article:15963092	pubmed:dateRevised	2009-11-18	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:meshHeading	pubmed-meshheading:15963092...	lld:pubmed
pubmed-article:15963092	pubmed:year	2005	lld:pubmed
pubmed-article:15963092	pubmed:articleTitle	Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study.	lld:pubmed
pubmed-article:15963092	pubmed:affiliation	Novartis Pharma AG, Basel, Switzerland. heinz.schmidli@pharma.novartis.com	lld:pubmed
pubmed-article:15963092	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:15963092	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:15963092	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:15963092	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:15963092	pubmed:publicationType	Clinical Trial, Phase III	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15963092	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15963092	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15963092	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15963092	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15963092	lld:pubmed